Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis.

Front Pharmacol · 2024 · PMC11039836 · PMID 38659584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When compared with placebo, ritlecitinib 10mg and ivarmacitinib 8mg/4mg/2mg did not reach statistical significance in achieving SALT 75 ( Figure 6B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.